Cardinal Health, Inc. (CAH)
NYSE: CAH · Real-Time Price · USD
228.52
-0.20 (-0.09%)
At close: Jul 17, 2026, 4:00 PM EDT
228.00
-0.52 (-0.23%)
After-hours: Jul 17, 2026, 7:33 PM EDT
Cardinal Health Stock Forecast
Stock Price Forecast
According to 17 analysts polled by S&P Global, Cardinal Health stock has a consensus rating of "Strong Buy" and an average price target of $249.6. The average 1-year stock price forecast is 9.22% higher than the current stock price, while the lowest is $215 (-5.92%) and the highest is $275 (+20.34%).
Price Target: $249.6 (+9.22%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Cardinal Health stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 11 | 11 | 12 | 12 | 12 | 12 |
| Buy | 2 | 2 | 3 | 2 | 2 | 2 |
| Hold | 4 | 4 | 2 | 3 | 3 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 17 | 17 | 17 | 17 | 17 | 17 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| TD Cowen | TD Cowen | Buy Maintains $255 → $275 | Buy | Maintains | $255 → $275 | +20.34% | Jul 9, 2026 |
| Bank of America Securities | Bank of America Securities | Buy Maintains $240 → $260 | Buy | Maintains | $240 → $260 | +13.78% | Jul 2, 2026 |
Unknown Analyst William O'Neil No rating | William O'Neil | Buy Initiates n/a | Buy | Initiates | n/a | n/a | Jun 12, 2026 |
| Barclays | Barclays | Buy Maintains $258 | Buy | Maintains | $258 | +12.90% | Jun 10, 2026 |
| Morgan Stanley | Morgan Stanley | Buy Reiterates $255 | Buy | Reiterates | $255 | +11.59% | May 5, 2026 |
Financial Forecast
Revenue This Year
255.82B
from 222.58B
Increased by 14.94%
Revenue Next Year
276.79B
from 255.82B
Increased by 8.19%
EPS This Year
10.78
from 8.24
Increased by 30.77%
EPS Next Year
12.03
from 10.78
Increased by 11.66%
EPS and Forward PE are based on non-GAAP adjusted numbers.